Bekir Cinar
- Cell Biology top 5%
- Hippo pathway signaling and YAP/TAZ 11
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism 4
-
- Prostate Cancer Treatment and Research 14
- Genetics top 10%
- Estrogen and related hormone effects 8
-
- Ubiquitin and proteasome pathways 6
- PI3K/AKT/mTOR signaling in cancer 5
-
- Cancer-related Molecular Pathways 3
-
- Cholesterol and Lipid Metabolism 2
- Co-authors
- Michael R. FreemanNishit K. MukhopadhyayRosalyn M. AdamDolores Di VizioAhmet AlptekinJayoung KimMichael L. LuArrigo De Benedetti
- Journals
- Cancer Research (5 papers)Journal of Biological Chemistry (4 papers)Leukemia Research (2 papers)
- Partner nations
- United StatesTürkiyeNetherlands
In The Last Decade
Bekir Cinar
29 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 75
- Cell Biology 367
- Cancer Research 255
- Pulmonary and Respiratory Medicine 424
- Genetics 111
- Molecular Biology 686
Countries citing papers authored by Bekir Cinar
This map shows the geographic impact of Bekir Cinar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bekir Cinar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bekir Cinar more than expected).
Fields of papers citing papers by Bekir Cinar
This network shows the impact of papers produced by Bekir Cinar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bekir Cinar. The network helps show where Bekir Cinar may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bekir Cinar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 1 | |
| 2 | 2020 | 12 | |
| 3 | 2018 | 9 | |
| 4 | 2017 | 25 | |
| 5 | 2015 | 89 | |
| 6 | 2014 | 34 | |
| 7 | 2013 | 26 | |
| 8 | 2013 | 101 | |
| 9 | 2012 | 50 | |
| 10 | 2011 | 34 | |
| 11 | 2011 | 62 | |
| 12 | 2009 | 56 | |
| 13 | 2007 | 107 | |
| 14 | 2007 | 75 | |
| 15 | 2007 | 112 | |
| 16 | 2006 | 49 | |
| 17 | 2006 | 28 | |
| 18 | 2005 | 59 | |
| 19 | 2005 | 82 | |
| 20 | 2000 | 25 |
About Bekir Cinar
Bekir Cinar is a scholar working on Cell Biology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 29 papers that have together received 1.3k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (14 papers), Hippo pathway signaling and YAP/TAZ (11 papers), Estrogen and related hormone effects (8 papers), Ubiquitin and proteasome pathways (6 papers), PI3K/AKT/mTOR signaling in cancer (5 papers), Cancer, Lipids, and Metabolism (4 papers), Cancer-related Molecular Pathways (3 papers) and Cholesterol and Lipid Metabolism (2 papers). The work is most often cited by research in Cell Biology (367 citations), Cancer Research (255 citations) and Pulmonary and Respiratory Medicine (424 citations). Bekir Cinar has collaborated with scholars based in United States, Türkiye and Netherlands. Frequent co-authors include Michael R. Freeman, Nishit K. Mukhopadhyay, Rosalyn M. Adam, Dolores Di Vizio, Ahmet Alptekin, Jayoung Kim, Michael L. Lu, Arrigo De Benedetti, Serhan Alkan and Keith R. Solomon. Their work appears in journals such as Cancer Research, Journal of Biological Chemistry, Leukemia Research, Scientific Reports and Trends in Endocrinology and Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.